Front. Cell. Neurosci.
Frontiers in Cellular Neuroscience
Front. Cell. Neurosci.
1662-5102
Frontiers Media S.A.
10.3389/fncel.2025.1739705
Correction
Correction: CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders
Shamsi Anas 1
Alrouji Mohammed 2 *
AlOmeir Othman 3
Tasqeruddin Syed 4
Dinislam Khuzin 5
Zuberi Azna 6 *
1 Centre of Medical and Bio-allied Health Sciences Research, Ajman University , Ajman , United Arab Emirates 2 Department of Medical Laboratories, College of Applied Medical Sciences, Shaqra University , Shaqra , Saudi Arabia 3 Department of Clinical Pharmacy, College of Pharmacy, Shaqra University , Shaqra , Saudi Arabia 4 Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University , Abha , Saudi Arabia 5 Department of General Chemistry, Bashkir State Medical University , Ufa , Russia 6 Department of Obstetrics and Gynecology, Northwestern University , Chicago, IL , United States
* Correspondence: Azna Zuberi, azna.zuberi@northwestern.edu ; Mohammed Alrouji, malrouji@su.edu.sa
24
11
2025
2025
19
1739705
05
11
2025
09
11
2025
10
11
2025
Copyright © 2025 Shamsi, Alrouji, AlOmeir, Tasqeruddin, Dinislam and Zuberi.
2025
Shamsi, Alrouji, AlOmeir, Tasqeruddin, Dinislam and Zuberi
https://creativecommons.org/licenses/by/4.0/
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Correction on CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders by Shamsi, A., Alrouji, M., AlOmeir, O., Tasqeruddin, S., Dinislam, K., and Zuberi, A. (2025). Front. Cell. Neuroscience . 19:1681891. doi: 10.3389/fncel.2025.1681891
CRISPR-Cas9
gene editing
neurodegenerative diseases
Alzheimer's disease
Parkinson's disease
Huntington's disease
amyotrophic lateral sclerosis (ALS)
aging
section-at-acceptance
Cellular Neuropathology
In the published article, in the author list, the fifth author's name was erroneously spelled as “Khzuin Dinislam” instead of the correctly spelt version “Khuzin Dinislam”.
The original version of this article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Approved by: Frontiers Editorial Office , Frontiers Media SA, Switzerland